Caustic Soda Antitrust Litigation

Court: United States District Court for the Western District of New York

Precious Plate, Inc., et al. v. Olin Corporation, et. al., Case No.: 19-cv-00385

Sodium hydroxide, commonly known as caustic soda, is a commodity chemical used in various industries, including paper, chemical production, food processing, and textiles. From approximately 2012 until late 2015, caustic soda prices were either declining or flat due to industry overcapacity and flat demand. It is alleged that these conditions motivated the Defendants to conspire and combine to restrict the domestic supply of caustic soda, of which they control an estimated 90%.

Under this alleged scheme, Defendants are accused of fixing, raising, maintaining, and stabilizing the price at which caustic soda was and continues to be sold, as well as allocating or refusing to supply customers and refusing to bid on contracts while falsely claiming supply was tight or scarce.

The alleged conspiracy was facilitated by secret co-producer supply agreements between and among Defendants and their agents – both directly with each other and indirectly through third parties – by manipulation of a price index and by the characteristics of the industry.

Average quarterly North American undiscounted Caustic Soda prices declined approximately 6% between the fourth quarter of 2012 through the third quarter of 2015. However, the Defendants implemented numerous across-the-board price increases of more than 50% in the fourth quarter of 2015 that affected all caustic soda purchasers. As a result of Defendant’s alleged unlawful conduct, caustic soda prices in the U.S. paid by Plaintiff have been artificially increased by a substantial amount and maintained above levels that would be expected due to supply and demand conditions.

WBE filed this case in July 2019 on behalf of the Plaintiffs and a putative class of indirect purchasers for the harm caused by Defendants’ conduct.

Click here to view a copy of the complaint.

 

 

News Articles

WBE Ranked in Chambers & Partners 2026 USA Spotlight

WBE is proud to announce the firm has been ranked for the second year by Chambers & Partners in their Spotlight Illinois guide. WBE was recognized for our work in General Litigation, and is ...

Court Grants Final Approval of $2.25 Million Settlement in Effexor XR Antitrust Litigation

On Tuesday, August 19, 2025, United States District Judge Zahid N. Quraishi of the District of New Jersey granted final approval of Indirect Purchaser Plaintiffs’ $2.25 million class-action ...

Court Grants Plaintiffs’ Motion for Summary Judgment in Part in Actos Antitrust Litigation

On Monday, March 31, 2025, U.S. District Court Judge Ronnie Abrams of the Southern District of New York partially granted summary judgment to two classes of Plaintiffs who purchased the diabetes ...